The PE Ratio as of December 2025 (TTM) for Concord Biotech Limited (CONCORDBIO.BO) is 45.45

According to Concord Biotech Limited’s latest financial reports and current stock price. The company's current PE Ratio is 45.45. This represents a change of -36.13% compared to the average of 71.16 of the last 4 quarters.

Concord Biotech Limited (CONCORDBIO.BO) Historical PE Ratio (quarterly & annually)

How has CONCORDBIO.BO PE Ratio performed in the past?

The mean historical PE Ratio of Concord Biotech Limited over the last ten years is 49.19. The current 45.45 PE Ratio has changed 9.14% with respect to the historical average. Over the past ten years (40 quarters), CONCORDBIO.BO's PE Ratio was at its highest in in the September 2022 quarter at 112.24. The PE Ratio was at its lowest in in the March 2023 quarter at 26.93.

Concord Biotech Limited (CONCORDBIO.BO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Concord Biotech Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Concord Biotech Limited (CONCORDBIO.BO) Average PE Ratio

How has CONCORDBIO.BO PE Ratio performed in the past?

The current PE Ratio of Concord Biotech Limited (CONCORDBIO.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Concord Biotech Limited (CONCORDBIO.BO) PE Ratio vs. Peers

How is CONCORDBIO.BO’s PE Ratio compared to its peers?

Concord Biotech Limited’s PE Ratio is greater than Blue Jet Healthcare Limited (26.81), greater than Blue Jet Healthcare Limited (26.81), greater than Caplin Point Laboratories Limited (25.35), greater than Jubilant Ingrevia Limited (37.71), greater than NATCO Pharma Limited (9.85), greater than NATCO Pharma Limited (9.85), greater than Granules India Limited (26.55), greater than Granules India Limited (26.55), less than Rainbow Children's Medicare Limited (53.28), less than Rainbow Children's Medicare Limited (53.28),

Build a custom stock screener for Concord Biotech Limited (CONCORDBIO.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Concord Biotech Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Concord Biotech Limited (CONCORDBIO.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Concord Biotech Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.